Page last updated: 2024-10-25

dapsone and Colorectal Neoplasms

dapsone has been researched along with Colorectal Neoplasms in 2 studies

Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.

Research Excerpts

ExcerptRelevanceReference
"Dapsone was stopped and symptoms resolved within 24 hours."1.32[Dapsone-induced sensory peripheral neuropathy]. ( Dega, H; Dubertret, L; Méry, L; Prost, C, 2003)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belum, VR1
Marchetti, MA1
Dusza, SW1
Cercek, A1
Kemeny, NE1
Lacouture, ME1
Méry, L1
Dega, H1
Prost, C1
Dubertret, L1

Trials

1 trial available for dapsone and Colorectal Neoplasms

ArticleYear
A prospective, randomized, double-blinded, split-face/chest study of prophylactic topical dapsone 5% gel versus moisturizer for the prevention of cetuximab-induced acneiform rash.
    Journal of the American Academy of Dermatology, 2017, Volume: 77, Issue:3

    Topics: Acneiform Eruptions; Adult; Aged; Anti-Infective Agents; Antineoplastic Agents; Carcinoma, Squamous

2017

Other Studies

1 other study available for dapsone and Colorectal Neoplasms

ArticleYear
[Dapsone-induced sensory peripheral neuropathy].
    Annales de dermatologie et de venereologie, 2003, Volume: 130, Issue:4

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Colorectal Neoplasms; Dapsone; Diagnosis, Differentia

2003